Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 3
2005 2
2006 6
2007 8
2008 6
2009 5
2010 4
2011 5
2012 7
2013 6
2014 8
2015 2
2016 6
2017 20
2018 12
2019 18
2020 12
2021 16
2022 10
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Current perspective on pediatric pharmacogenomics.
Abaji R, Krajinovic M. Abaji R, et al. Among authors: krajinovic m. Expert Opin Drug Metab Toxicol. 2016;12(4):363-5. doi: 10.1517/17425255.2016.1145656. Epub 2016 Feb 15. Expert Opin Drug Metab Toxicol. 2016. PMID: 26799591 No abstract available.
Pharmacogenetics of asparaginase in acute lymphoblastic leukemia.
Abaji R, Krajinovic M. Abaji R, et al. Among authors: krajinovic m. Cancer Drug Resist. 2019 Jun 19;2(2):242-255. doi: 10.20517/cdr.2018.24. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582721 Free PMC article. Review.
Pharmacogenetic Expression of CYP2C19 in a Pediatric Population.
Pierre-François MJD, Gagné V, Brukner I, Krajinovic M. Pierre-François MJD, et al. Among authors: krajinovic m. J Pers Med. 2022 Aug 26;12(9):1383. doi: 10.3390/jpm12091383. J Pers Med. 2022. PMID: 36143168 Free PMC article. Review.
Novel therapy for childhood acute lymphoblastic leukemia.
Santiago R, Vairy S, Sinnett D, Krajinovic M, Bittencourt H. Santiago R, et al. Among authors: krajinovic m. Expert Opin Pharmacother. 2017 Aug;18(11):1081-1099. doi: 10.1080/14656566.2017.1340938. Epub 2017 Jun 26. Expert Opin Pharmacother. 2017. PMID: 28608730 Review.
Steroid responsiveness and wheezing phenotypes.
Ducharme FM, Krajinovic M. Ducharme FM, et al. Among authors: krajinovic m. Paediatr Respir Rev. 2011 Sep;12(3):170-6. doi: 10.1016/j.prrv.2011.02.007. Paediatr Respir Rev. 2011. PMID: 21722845 Free PMC article. Review.
Pharmacogenomics of acute leukemia.
Ansari M, Krajinovic M. Ansari M, et al. Among authors: krajinovic m. Pharmacogenomics. 2007 Jul;8(7):817-34. doi: 10.2217/14622416.8.7.817. Pharmacogenomics. 2007. PMID: 18240908 Review.
Pharmacogenetics of methotrexate.
Krajinovic M, Moghrabi A. Krajinovic M, et al. Pharmacogenomics. 2004 Oct;5(7):819-34. doi: 10.1517/14622416.5.7.819. Pharmacogenomics. 2004. PMID: 15469405 Review.
Pharmacogenetics of drug response in Parkinson's disease.
Džoljić E, Novaković I, Krajinovic M, Grbatinić I, Kostić V. Džoljić E, et al. Among authors: krajinovic m. Int J Neurosci. 2015;125(9):635-44. doi: 10.3109/00207454.2014.963851. Epub 2014 Oct 15. Int J Neurosci. 2015. PMID: 25226559 Review.
Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.
Dulucq S, Laverdière C, Sinnett D, Krajinovic M. Dulucq S, et al. Among authors: krajinovic m. Expert Opin Drug Metab Toxicol. 2014 May;10(5):699-719. doi: 10.1517/17425255.2014.893294. Epub 2014 Mar 27. Expert Opin Drug Metab Toxicol. 2014. PMID: 24673379 Review.
160 results